Amgen earnings boosted by Horizon deal, Gilead quarterly revenue drops

Amgen earnings boosted by Horizon deal, Gilead quarterly revenue drops

Source: 
Medical Marketing and Media
snippet: 

The long-awaited closing of Amgen’s nearly $28 billion deal for Horizon Therapeutics boosted the pharma giant’s latest quarterly earnings released Tuesday afternoon.